Education
About Us
Working with TipRanks
Follow Us
NeOnc Technologies Holdings, Inc. (NTHI)
:NTHI
NTHI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.20 - $25.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)233.75K
Market Cap
N/A
Enterprise Value$68.20M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.89
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,159,119
10 Day Avg. Volume59,314
30 Day Avg. Volume233,755
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NeOnc Technologies Holdings, Inc. News
NTHI FAQ
What was NeOnc Technologies Holdings, Inc.’s price range in the past 12 months?
NeOnc Technologies Holdings, Inc. lowest stock price was $3.20 and its highest was $25.00 in the past 12 months.
What is NeOnc Technologies Holdings, Inc.’s market cap?
Currently, no data Available
When is NeOnc Technologies Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NeOnc Technologies Holdings, Inc.’s earnings last quarter?
NeOnc Technologies Holdings, Inc. released its earnings results on Aug 19, 2025. The company reported -$0.298 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.298.
Is NeOnc Technologies Holdings, Inc. overvalued?
According to Wall Street analysts NeOnc Technologies Holdings, Inc.’s price is currently Overvalued.
Does NeOnc Technologies Holdings, Inc. pay dividends?
NeOnc Technologies Holdings, Inc. does not currently pay dividends.
What is NeOnc Technologies Holdings, Inc.’s EPS estimate?
NeOnc Technologies Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NeOnc Technologies Holdings, Inc. have?
NeOnc Technologies Holdings, Inc. has 19,159,119 shares outstanding.
What happened to NeOnc Technologies Holdings, Inc.’s price movement after its last earnings report?
NeOnc Technologies Holdings, Inc. reported an EPS of -$0.298 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.166%.
Which hedge fund is a major shareholder of NeOnc Technologies Holdings, Inc.?
Currently, no hedge funds are holding shares in NTHI
Company Description
NeOnc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Technical Analysis
Ownership Overview
59.59% Insiders
0.62% Other Institutional Investors
39.76% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---